Cytek Biosciences Affirms FY2026 Sales Guidance of $205.000M-$212.000M vs $208.235M Est

Benzinga Newsdesk www.benzinga.com Negative 66.6%

Neg 66.6% Neu 0% Pos 0%

Cytek Biosciences (NASDAQ:CTKB) affirms FY2026 sales outlook from $205.000 million-$212.000 million to $205.000 million-$212.000 million vs $208.235 million estimate.